Literature DB >> 12943728

Salt-inducible kinase-mediated regulation of steroidogenesis at the early stage of ACTH-stimulation.

Hiroshi Takemori1, Junko Doi, Nanao Horike, Yoshiko Katoh, Li Min, Xing-zi Lin, Zin-nong Wang, Masaaki Muraoka, Mitsuhiro Okamoto.   

Abstract

Salt-inducible kinase (SIK), expressed in Y1 mouse adrenocortical tumor cells at an early stage of adrenocorticotropic hormone (ACTH)-stimulation, represses the cAMP-responsive element (CRE)-dependent gene expression of CYP11A and StAR by acting on bZIP domain of CRE-binding protein. ACTH induced the SIK's nuclear to cytosolic translocation in a PKA-dependent manner. A mutant SIK in which the PKA-dependently phosphorylatable Ser577 had been replaced with Ala could not move out of the nucleus. The degree of CRE-reporter repression by SIK was strong as long as SIK was present in the nucleus. These indicated that intracellular translocation of SIK might be an important factor to determine the time-dependent change in the level of steroidogenic gene expression in ACTH-stimulated cells. Promoter analyses suggested that SIK repressed gene expressions not only of CYP11A and StAR but also of CYP11B1, CYP11B2 and SIK itself. We propose here that SIK is one of important molecule regulating expression of steroidogenic genes in the early phase of ACTH treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943728     DOI: 10.1016/s0960-0760(03)00199-7

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  6 in total

1.  Stimulation of StAR expression by cAMP is controlled by inhibition of highly inducible SIK1 via CRTC2, a co-activator of CREB.

Authors:  Jinwoo Lee; Tiegang Tong; Hiroshi Takemori; Colin Jefcoate
Journal:  Mol Cell Endocrinol       Date:  2015-02-07       Impact factor: 4.102

Review 2.  The LKB1 complex-AMPK pathway: the tree that hides the forest.

Authors:  Michaël Sebbagh; Sylviane Olschwang; Marie-Josée Santoni; Jean-Paul Borg
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

3.  De novo mutations in SIK1 cause a spectrum of developmental epilepsies.

Authors:  Jeanne Hansen; Chelsi Snow; Emily Tuttle; Dalia H Ghoneim; Chun-Song Yang; Adam Spencer; Sonya A Gunter; Christopher D Smyser; Christina A Gurnett; Marwan Shinawi; William B Dobyns; James Wheless; Marc W Halterman; Laura A Jansen; Bryce M Paschal; Alex R Paciorkowski
Journal:  Am J Hum Genet       Date:  2015-04-02       Impact factor: 11.025

4.  Regulation of SIK1 abundance and stability is critical for myogenesis.

Authors:  Randi Stewart; Dmitry Akhmedov; Christopher Robb; Courtney Leiter; Rebecca Berdeaux
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-19       Impact factor: 11.205

5.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

6.  Multiple Signaling Pathways Coordinate CYP17 Gene Expression in the Human Adrenal Cortex.

Authors:  Marion B Sewer; Donghui Li; Eric B Dammer; Srinath Jagarlapudi; Natasha Lucki
Journal:  Acta Chim Slov       Date:  2008-01-01       Impact factor: 1.735

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.